Strata Critical Medical, Inc. (SRTA)
| Market Cap | 451.18M +2.3% |
| Revenue (ttm) | 255.98M +66.8% |
| Net Income | 40.22M |
| EPS | 0.47 |
| Shares Out | 88.47M |
| PE Ratio | 11.22 |
| Forward PE | 120.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,216,151 |
| Open | 5.29 |
| Previous Close | 5.23 |
| Day's Range | 5.01 - 5.34 |
| 52-Week Range | 3.95 - 6.50 |
| Beta | 2.26 |
| Analysts | Strong Buy |
| Price Target | 9.56 (+87.45%) |
| Est. Earnings | Nov 9, 2026 |
About SRTA
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perf... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for SRTA stock is "Strong Buy." The 12-month stock price target is $9.56, which is an increase of 87.45% from the latest price.
News
Strata Critical Medical Transcript: 2026 Jefferies Healthcare Services and Technology Conference
Organ transplant logistics and clinical services are rapidly evolving due to regulatory and technological advances, with strong growth in Donation after Circulatory Death and perfusion services. The business leverages an asset-light, national platform and aggressive acquisition strategy to outpace industry growth and improve efficiency.
Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 2026 Jefferies Healthcare Serv...
Strata Critical Medical management to meet with Craig-Hallum
Meeting to be held in Minneapolis on August 11-12 hosted by Craig-Hallum.
Strata Critical Medical Earnings Call Transcript: Q2 2026
Q2 2026 saw strong clinical growth, improved cash flow, and strategic acquisitions, offset by a temporary logistics revenue dip due to a unique customer event. Guidance for 2026 was raised on both revenue and EBITDA, with clinical margins and business mix expected to improve further.
Strata Critical Medical Earnings release: Q2 2026
Strata Critical Medical released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Strata Critical Medical Slides: Q2 2026
Strata Critical Medical has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Strata Critical Medical Quarterly report: Q2 2026
Strata Critical Medical has published its Q2 2026 quarterly earnings report on August 4, 2026.
Strata Critical Medical Announces Second Quarter 2026 Results
Revenue increased 60.7% year-over-year to $72.5 million in Q2 2026 Clinical revenue increased 22.6% sequentially in Q2 2026; Excluding Clinical acquisitions that closed in Q2 2026, Clinical revenue in...
Strata Critical Medical Slides: Investor presentation
Strata Critical Medical has posted slides in relation to its latest quarterly earnings report, which was published on August 4, 2026.
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the second quarter ended July 31, 2026 on Tuesday, Au...
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
Network of experienced transplant surgeons in key markets will immediately become available to all Strata customers Adds significant scale to Transplant Clinical, Strata's fastest growing business lin...
Strata Critical Medical management to meet with B. Riley
Meeting to be held in Canada on June 22-23 hosted by B. Riley.
Strata Critical Medical Transcript: 16th Annual East Coast IDEAS Conference
The company has transformed into a leading, integrated transplant logistics and clinical services provider, achieving rapid organic growth and leveraging regulatory and technological trends to outpace industry expansion. Strong financials and a flexible, asset-light model support ongoing M&A and organic growth initiatives.
Strata Acquires Louisville Perfusion Services
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that it has completed the acquisition of Louisville Perfusion Servi...
Strata Critical Medical Transcript: AGM 2026
The meeting featured board leadership transitions, approval of all shareholder proposals—including director elections, auditor ratification, and executive compensation—and reaffirmed corporate governance practices. Stockholders were encouraged to participate in Q&A and future compensation decisions will reflect their input.
AIAI Holdings Corporation Announces Appointment of Board of Directors
Directors bring a strong combination of technology, healthcare, national security, leadership experience, and financial and capital markets backgrounds AIAI Expected to Begin Trading on May 14, 2026 ...
Strata Critical Medical Slides: Investor presentation
Strata Critical Medical has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
Strata Critical Medical Announces Expiration of Warrants
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), announced that its warrants, both the Public Warrants (Nasdaq: SRTAW) and the Privat...
Strata Critical Medical price target raised to $11.50 from $11.25 at Ladenburg
Ladenburg analyst Jon Hickman raised the firm’s price target on Strata Critical Medical (SRTA) to $11.50 from $11.25 and keeps a Buy rating on the shares.
Strata Critical Medical reports Q1 EPS 3c, consensus (4c)
Reports Q1 revenue $67.38M, consensus $63.67M. “We are pleased to report Q1 results that came in ahead of our expectations, reflecting both strong execution on our growth plan and improving…
Strata Critical Medical backs FY26 revenue view $260M-$275M, consensus $269.18M
Backs FY26 adjusted EBITDA view $29M-$33M. “The underlying strength of our transformed economic model is finally shining through as we began generating operating cash flow this quarter. Our quality of...
Strata Critical Medical Earnings Call Transcript: Q1 2026
Q1 2026 saw 87% revenue growth, strong clinical and logistics performance, and positive cash flow. Guidance for 2026 is reiterated, with continued M&A activity and industry trends supporting growth. Cash and liquidity remain robust.
Strata Critical Medical Earnings release: Q1 2026
Strata Critical Medical released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Strata Critical Medical Slides: Q1 2026
Strata Critical Medical has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Strata Critical Medical Quarterly report: Q1 2026
Strata Critical Medical has published its Q1 2026 quarterly earnings report on May 6, 2026.